Foodborne parasite sparks surge in cyclosporiasis outbreak

Cyclosporiasis — a foodborne illness caused by a parasite that lives on fruits and vegetables — has surged in several parts of the country, according to federal and state health officials.
At least 18 states have reported cases of cyclosporiasis, which, the CDC says, can cause bouts of “watery diarrhea” and “explosive bowel movements.”
Health officials have not identified an outbreak source, and that is a cause for concern, said David O. Freedman, MD, FIDSA, professor emeritus of infectious diseases at the University of Alabama at Birmingham.
“Usually, by this point, they’ve been able to

Retirement presents a new chapter full of opportunities

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
We spend so much time talking about our journey into ophthalmology — how to build a practice, run it and make it grow — but we rarely discuss the other end of our journey into retirement and beyond. From the experience of two esteemed colleagues, Cynthia Matossian, MD, FACS, and Denise M. Visco, MD, MBA, you will learn that retirement, far from being the end of the story, can be the start of a new

Exploring the brain-skin connection in geriatric psychodermatology

As the geriatric population continues to grow, dermatologists are raising awareness of psychocutaneous diseases, a group of skin conditions that commonly affect older adults.
According to data from the U.S. Census Bureau, the number of Americans aged 65 years and older is projected to reach 82 million by 2050, making this age group 23% of the nation’s population. This population increasingly faces a class of skin conditions known as psychocutaneous diseases, which is underdiagnosed and undertreated by many physicians, according to Shari R. Lipner, MD, PhD, FAAD, a dermatologist at Weill

Preoperative radiation may enhance brain metastases treatment

Preoperative radiation therapy targeting brain metastases can activate immune pathways that typically are suppressed, results of a retrospective, observational study showed.
Ionizing radiation enhanced T-cell receptor diversity and upregulated antigen presentation within the brain metastases microenvironment.
Patients with enriched T-cell receptor diversity, as well as greater presence and density of tumor-infiltrating lymphocytes (TILs), exhibited favorable prognoses. The enhanced cellular immunity could make tumors more receptive to immunotherapy, according to investigators.
“It certainly is

Omnipod 6 improves time in range for adults with type 2 diabetes

NEW ORLEANS — Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin delivery system compared with Omnipod 5, according to data from the STRIVE trial.
As Healio previously reported, the Omnipod 6 (Insulet) was associated with noninferior time in range, time in hypoglycemia, time in severe hypoglycemia and mean glucose for adults with diabetes in the STRIVE trial. In a subanalysis of the trial presented at the American Diabetes Association Scientific Sessions, researchers found Omnipod 6 was noninferior to Omnipod 5 for time in

‘Unlearning learned helplessness’ in medicine requires partnership of physicians, patients

In Healio Community’s June book club, Todd R. Otten, MD, FAAP, shared the impetus behind his book, Ripple of Change, a collaborative story of physician and patient burnout caused by an impaired American health care system in need of change.
Otten, a family physician and Naval flight surgeon, coauthored this book with his patient, Joshua Judy, to encourage stakeholders to reconceptualize the system and consider the well-being of both doctors and patients.
Hansa Bhargava, MD, chief clinical strategy and innovation officer at Healio, emphasized the book’s timely relevance.
“So many of us actually

Berotralstat reduces HAE attacks requiring on-demand treatment

Following receipt of once-daily berotralstat, pediatric patients with hereditary angioedema had a reduced rate of attacks requiring on-demand treatment early on in treatment, according to an updated interim analysis of the APeX-P study.
These data on berotralstat (Orladeyo, BioCryst) were presented in a poster at the 2026 European Academy of Allergy and Clinical Immunology Annual Congress.
“Analysis of 48-week trial data showed that treatment with Orladeyo was associated with early and sustained reductions in rate and number of [hereditary angioedema (HAE)] attacks requiring on-demand treatment